Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Other Non-Current Liabilities (2016 - 2025)

Historic Other Non-Current Liabilities for Conmed (CNMD) over the last 16 years, with Q4 2025 value amounting to $63.9 million.

  • Conmed's Other Non-Current Liabilities fell 2600.76% to $63.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $63.9 million, marking a year-over-year decrease of 2600.76%. This contributed to the annual value of $63.9 million for FY2025, which is 2600.76% down from last year.
  • Conmed's Other Non-Current Liabilities amounted to $63.9 million in Q4 2025, which was down 2600.76% from $71.7 million recorded in Q3 2025.
  • In the past 5 years, Conmed's Other Non-Current Liabilities registered a high of $218.1 million during Q3 2022, and its lowest value of $41.8 million during Q1 2022.
  • Over the past 5 years, Conmed's median Other Non-Current Liabilities value was $90.5 million (recorded in 2024), while the average stood at $103.6 million.
  • Per our database at Business Quant, Conmed's Other Non-Current Liabilities skyrocketed by 37379.51% in 2022 and then crashed by 4140.76% in 2024.
  • Over the past 5 years, Conmed's Other Non-Current Liabilities (Quarter) stood at $43.0 million in 2021, then soared by 373.8% to $203.7 million in 2022, then tumbled by 40.58% to $121.0 million in 2023, then decreased by 28.7% to $86.3 million in 2024, then dropped by 26.01% to $63.9 million in 2025.
  • Its last three reported values are $63.9 million in Q4 2025, $71.7 million for Q3 2025, and $79.8 million during Q2 2025.